Malignant lymphoma of the testis: A study of 12 cases

Journal of the Canadian Urological Association

Volumn 3, Issue 5, 2009, Pages 393-398

  Lantz, Andrea G ^a   Power, Nicholas ^b   Hutton, Brian ^c   Gupta, Rekha ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350499204     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29: 252-60.
2. Linassier C, Desablens B, Lefrancq T, et al. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: Results of a prospective trial by the GOELAMS study group. Clin Lymphoma 2002;3(3):167-72.
3. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003;21:20-7.
4. Shahab N, Doll DC. Testicular lymphoma. Semin Oncol 1999;26:259-69.
5. Zucca E, Roggero E, Bertoni F, et al. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-37.
6. Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994;18: 376-90.
7. Darby S, Hancock BW. Localised non-Hodgkin lymphoma of the testis: The Sheffield Lymphoma Group experience. Int J Oncol 2005;26:1093-9.
8. Aviles A, Neri N, Huerta-Guzman J, et al. Testicular lymphoma: Organ-specific treatment did not improve outcome. Oncology 2004;67:211-4.
9. Lagrange JL, Ramaioli A, Theodore CH, et al. Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol 2001;12:1313-9.
10. Zouhair A, Weber D, Belkacemi Y, et al. Outcome and patterns of failure in testicular lymphoma: A multi center rare cancer network study. Int J Radiat Oncol Biol Phys 2002;52:652-6.
11. Hasselblom S, Ridell B, Wedel H, et al. Testicular lymphoma-a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol 2004;43:758-65.
12. Tondini C, Ferreri AJ, Siracusano L, et al.Diffuse large-cell lymphoma of the testis. J Clin Oncol 1999;17: 2854-8.
13. Sasai K, Yamabe H, Tsutsui K, et al. Primary testicular non-Hodgkin's lymphoma: a clinical study and review of the literature. Am J Clin Oncol 1997;20:59-62.
14. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000;88:154-61. (Pubitemid 30027691)
15. Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995;13:1361-7.
16. Seymour JF, Solomon B, Wolf MM, et al. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma 2001;2:109-15.
17. Moormeier JA, Williams SF, Golomb HM. The staging of non-Hodgkin's lymphomas. Semin Oncol 1990;17:43-50.
18. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-94.
19. Visco C, Medeiros LJ, Mesina OM, et al. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy? Clin Lymphoma 2001;2:40-6.
20. Shenkier TN, Voss N, Fairey R, et al. Brief chemotherapy and involved-region irradiation for limitedstage diffuse large-cell lymphoma: An 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 2002;20:197-204.
21. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med 1986;81:515-24.
22. Connors JM. Problems in lymphoma management: special sites of presentation. Oncology (Williston Park) 1998;12:185, 91; discussion 192-5.
23. Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005;23:5027-33.